Last reviewed · How we verify
Vaccination against TBE
At a glance
| Generic name | Vaccination against TBE |
|---|---|
| Sponsor | Sormland County Council, Sweden |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) (PHASE4)
- Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (PHASE2)
- TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vaccination against TBE CI brief — competitive landscape report
- Vaccination against TBE updates RSS · CI watch RSS
- Sormland County Council, Sweden portfolio CI